Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
MAYNF MAYNE PHARMA GROUP LIMITED
0.154
+0.014+10.00%
All
YOY
Do not show
Business Unit:AUD
nameYOYOperating income%
Portfolio Products Division--269.09M63.48%
Metrics Contract Services--90.77M21.41%
International--54.37M12.83%
Branded Products Division--10.57M2.49%
Royalty revenue---882K-0.21%
Region Unit:AUD
nameYOYOperating income%
United States--370.92M87.32%
Australia And New Zealand--33.7M7.93%
Canada--9.06M2.13%
Europe--6.25M1.47%
Asia--4.88M1.15%
Company Overview More
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
CEO: Mr. Shawn Patrick O’Brien
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist